-
1
-
-
0028342736
-
2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells
-
2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Letters 348 192-196.
-
(1994)
FEBS Letters
, vol.348
, pp. 192-196
-
-
Akbar, M.1
Okajima, F.2
Tomura, H.3
Majid, M.A.4
Yamada, Y.5
Seino, S.6
Kondo, Y.7
-
2
-
-
0033054602
-
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegaly patients
-
Baldelli R, Ferretti E, Jaffrain-Rea M L, Iacobellis G, Minniti G, Caracciolo B, Moroni C, Cassone R, Gulino A & Tamburrano G 1999 Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegaly patients. Journal of Clinical Endocrinology and Metabolism 84 527-532.
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, pp. 527-532
-
-
Baldelli, R.1
Ferretti, E.2
Jaffrain-Rea, M.L.3
Iacobellis, G.4
Minniti, G.5
Caracciolo, B.6
Moroni, C.7
Cassone, R.8
Gulino, A.9
Tamburrano, G.10
-
3
-
-
0027142895
-
Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
-
Bruno JF, Xu Y, Song J & Berelowitz M 1993 Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133 2561-2567.
-
(1993)
Endocrinology
, vol.133
, pp. 2561-2567
-
-
Bruno, J.F.1
Xu, Y.2
Song, J.3
Berelowitz, M.4
-
4
-
-
0028929754
-
Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
-
Buscail L, Esteve J P, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll, AM, Bell G I, Schally A V, Vaysse N & Susini C 1995 Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. PNAS 92 1580-1584.
-
(1995)
PNAS
, vol.92
, pp. 1580-1584
-
-
Buscail, L.1
Esteve, J.P.2
Saint-Laurent, N.3
Bertrand, V.4
Reisine, T.5
O'Carroll, A.M.6
Bell, G.I.7
Schally, A.V.8
Vaysse, N.9
Susini, C.10
-
5
-
-
0025605818
-
Cardiovascular effects of the somatostatin analog octreotide in acromegaly
-
Chanson P, Timsit J, Masquet C, Warnet A, Guillausseau P J, Birman P, Harris A G & Lubetzki J 1990 Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Annals of Internal Medicine 113 921-925.
-
(1990)
Annals of Internal Medicine
, vol.113
, pp. 921-925
-
-
Chanson, P.1
Timsit, J.2
Masquet, C.3
Warnet, A.4
Guillausseau, P.J.5
Birman, P.6
Harris, A.G.7
Lubetzki, J.8
-
6
-
-
0038646354
-
Cardiovascular function in acromegaly
-
Clayton RN 2003 Cardiovascular function in acromegaly. Endocrine Reviews 24 272-277.
-
(2003)
Endocrine Reviews
, vol.24
, pp. 272-277
-
-
Clayton, R.N.1
-
7
-
-
0032956615
-
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly
-
Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M & Lombardi G 1999 Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 84 17-23.
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, pp. 17-23
-
-
Colao, A.1
Cuocolo, A.2
Marzullo, P.3
Nicolai, E.4
Ferone, D.5
Florimonte, L.6
Salvatore, M.7
Lombardi, G.8
-
8
-
-
17744362863
-
Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy
-
Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G & Liuzzi A 2000a Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. Journal of Clinical Endocrinology and Metabolism 85 193-199.
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, pp. 193-199
-
-
Colao, A.1
Baldelli, R.2
Marzullo, P.3
Ferretti, E.4
Ferone, D.5
Gargiulo, P.6
Petretta, M.7
Tamburrano, G.8
Lombardi, G.9
Liuzzi, A.10
-
9
-
-
0033710082
-
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly
-
Colao A, Marzullo P, Ferone D, Spinelli L, Cuocolo A, Bonaduce D, Salvatore M, Boerlin V, Lancranjan I & Lombardi G 2000b Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. Journal of Clinical Endocrinology and Metabolism 85 3132-3140.
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, pp. 3132-3140
-
-
Colao, A.1
Marzullo, P.2
Ferone, D.3
Spinelli, L.4
Cuocolo, A.5
Bonaduce, D.6
Salvatore, M.7
Boerlin, V.8
Lancranjan, I.9
Lombardi, G.10
-
11
-
-
0035040518
-
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance
-
Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M & Lombardi G 2001b Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism 86 1551-1557.
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, pp. 1551-1557
-
-
Colao, A.1
Cuocolo, A.2
Marzullo, P.3
Nicolai, E.4
Ferone, D.5
Della Morte, A.M.6
Pivonello, R.7
Salvatore, M.8
Lombardi, G.9
-
12
-
-
0028860791
-
Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure
-
Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA & Harding SE 1995 Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92 2540-2549.
-
(1995)
Circulation
, vol.92
, pp. 2540-2549
-
-
Davies, C.H.1
Davia, K.2
Bennett, J.G.3
Pepper, J.R.4
Poole-Wilson, P.A.5
Harding, S.E.6
-
13
-
-
0028829102
-
Insulin-like growth factor I and its binding proteins in the cardiovascular system
-
Delafontaine P 1995 Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovascular Research 30 825-834.
-
(1995)
Cardiovascular Research
, vol.30
, pp. 825-834
-
-
Delafontaine, P.1
-
14
-
-
0031979411
-
Effects of octreotide in patients with hypertrophic obstructive cardiomyopathy
-
Demirtas E, Sag C, Kursaklioglu H, Uzun M, Uzbay T, Tore HF, Kose S, Genc C & Demirkan D 1998 Effects of octreotide in patients with hypertrophic obstructive cardiomyopathy. Japanese Heart Journal 39 173-181.
-
(1998)
Japanese Heart Journal
, vol.39
, pp. 173-181
-
-
Demirtas, E.1
Sag, C.2
Kursaklioglu, H.3
Uzun, M.4
Uzbay, T.5
Tore, H.F.6
Kose, S.7
Genc, C.8
Demirkan, D.9
-
15
-
-
0026787125
-
Octreotide treatment of acromegaly. A randomized, multicenter study
-
Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L & Cook DM 1992 Octreotide treatment of acromegaly. A randomized, multicenter study. Annals of Internal Medicine 117 711-718.
-
(1992)
Annals of Internal Medicine
, vol.117
, pp. 711-718
-
-
Ezzat, S.1
Snyder, P.J.2
Young, W.F.3
Boyajy, L.D.4
Newman, C.5
Klibanski, A.6
Molitch, M.E.7
Boyd, A.E.8
Sheeler, L.9
Cook, D.M.10
-
16
-
-
0033596928
-
Cell death in acromegalic cardiomyopathy
-
Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Leri A, Kajstura J, Anversa P & Maseri A 1999 Cell death in acromegalic cardiomyopathy. Circulation 99 1426-1434.
-
(1999)
Circulation
, vol.99
, pp. 1426-1434
-
-
Frustaci, A.1
Chimenti, C.2
Setoguchi, M.3
Guerra, S.4
Corsello, S.5
Crea, F.6
Leri, A.7
Kajstura, J.8
Anversa, P.9
Maseri, A.10
-
17
-
-
0026764441
-
Rational design of potent antagonists to the human growth hormone receptor
-
Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV & Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256 1677-1680.
-
(1992)
Science
, vol.256
, pp. 1677-1680
-
-
Fuh, G.1
Cunningham, B.C.2
Fukunaga, R.3
Nagata, S.4
Goeddel, D.V.5
Wells, J.A.6
-
18
-
-
0029801055
-
Short term reduction of left ventricular mass in primary hypertrophy cardiomyopathy by octreotide injections
-
Gunal AI, Isik A, Celiker H, Eren O, Celebi H, Gunal S Y & Luleci C 1996 Short term reduction of left ventricular mass in primary hypertrophy cardiomyopathy by octreotide injections. Heart 76 418-421.
-
(1996)
Heart
, vol.76
, pp. 418-421
-
-
Gunal, A.I.1
Isik, A.2
Celiker, H.3
Eren, O.4
Celebi, H.5
Gunal, S.Y.6
Luleci, C.7
-
20
-
-
0028035369
-
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy
-
Levy D, Salomon M, D'Agostino RB, Belanger AJ & Kannel WB 1994 Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90 1786-1793.
-
(1994)
Circulation
, vol.90
, pp. 1786-1793
-
-
Levy, D.1
Salomon, M.2
D'Agostino, R.B.3
Belanger, A.J.4
Kannel, W.B.5
-
21
-
-
0018871602
-
Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients
-
Lie JT 1980 Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal 100 41-52.
-
(1980)
American Heart Journal
, vol.100
, pp. 41-52
-
-
Lie, J.T.1
-
22
-
-
0026808556
-
Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion
-
Lim MJ, Barkan AL & Buda AJ 1992 Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Annals of Internal Medicine 117 719-726.
-
(1992)
Annals of Internal Medicine
, vol.117
, pp. 719-726
-
-
Lim, M.J.1
Barkan, A.L.2
Buda, A.J.3
-
23
-
-
0033223027
-
Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy
-
Manelli F, Desenzani P, Boni E, Bugari G, Negrini F, Romanelli G, Grassi V & Giustina A 1999 Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy. Pituitary 2 205-210.
-
(1999)
Pituitary
, vol.2
, pp. 205-210
-
-
Manelli, F.1
Desenzani, P.2
Boni, E.3
Bugari, G.4
Negrini, F.5
Romanelli, G.6
Grassi, V.7
Giustina, A.8
-
24
-
-
0035797832
-
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
-
Heart Outcomes Prevention Evaluation H
-
Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S & Heart Outcomes Prevention Evaluation H 2001 Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104 1615-1621.
-
(2001)
Circulation
, vol.104
, pp. 1615-1621
-
-
Mathew, J.1
Sleight, P.2
Lonn, E.3
Johnstone, D.4
Pogue, J.5
Yi, Q.6
Bosch, J.7
Sussex, B.8
Probstfield, J.9
Yusuf, S.10
-
25
-
-
0027433245
-
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly
-
Merola B, Cittadini A, Colao A, Ferone D, Fazio S, Sabatini D, Biondi, B, Sacca L & Lombardi G 1993 Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. Journal of Clinical Endocrinology and Metabolism 77 790-793.
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.77
, pp. 790-793
-
-
Merola, B.1
Cittadini, A.2
Colao, A.3
Ferone, D.4
Fazio, S.5
Sabatini, D.6
Biondi, B.7
Sacca, L.8
Lombardi, G.9
-
26
-
-
0026565418
-
Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: Calcium imaging and single channel recording
-
Morton AJ, Hammond C, Mason WT & Henderson G 1992 Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording. Brain Research Molecular Brain Research 13 53-61.
-
(1992)
Brain Research Molecular Brain Research
, vol.13
, pp. 53-61
-
-
Morton, A.J.1
Hammond, C.2
Mason, W.T.3
Henderson, G.4
-
31
-
-
0028308708
-
All five cloned human somatostatin receptors (HSSTR1-5) are functionally coupled to adenylyl cyclase
-
Patel YC, Greenwood MT, Warszynska A, Panetta R & Srikant CB 1994 All five cloned human somatostatin receptors (HSSTR1-5) are functionally coupled to adenylyl cyclase. Biochemical and Biophysical Research Communications 198 605-612.
-
(1994)
Biochemical and Biophysical Research Communications
, vol.198
, pp. 605-612
-
-
Patel, Y.C.1
Greenwood, M.T.2
Warszynska, A.3
Panetta, R.4
Srikant, C.B.5
-
32
-
-
0034677745
-
Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
-
Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC & Patel YC 2000 Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. Journal of Biological Chemistry 275 7862-7869.
-
(2000)
Journal of Biological Chemistry
, vol.275
, pp. 7862-7869
-
-
Rocheville, M.1
Lange, D.C.2
Kumar, U.3
Sasi, R.4
Patel, R.C.5
Patel, Y.C.6
-
33
-
-
0029959644
-
Subtype-selective induction of wild-type P53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
-
Sharma K, Patel YC & Srikant CB 1996 Subtype-selective induction of wild-type P53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Molecular Endocrinology 10 1688-1696.
-
(1996)
Molecular Endocrinology
, vol.10
, pp. 1688-1696
-
-
Sharma, K.1
Patel, Y.C.2
Srikant, C.B.3
-
34
-
-
0024397261
-
The cardiovascular effects of octreotide treatment in acromegaly: An echocardiographic study
-
Thuesen L, Christensen SE, Weeke J, Orskov H & Henningsen P 1989 The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clinical Endocrinology 30 619-625.
-
(1989)
Clinical Endocrinology
, vol.30
, pp. 619-625
-
-
Thuesen, L.1
Christensen, S.E.2
Weeke, J.3
Orskov, H.4
Henningsen, P.5
-
35
-
-
0027946110
-
Effects of octreotide on left ventricular mass in acromegaly
-
Tokgozoglu SL, Erbas T, Aytemir K, Akalin S, Kes S & Oram E 1994 Effects of octreotide on left ventricular mass in acromegaly. American Journal of Cardiology 74 1072-1074.
-
(1994)
American Journal of Cardiology
, vol.74
, pp. 1072-1074
-
-
Tokgozoglu, S.L.1
Erbas, T.2
Aytemir, K.3
Akalin, S.4
Kes, S.5
Oram, E.6
-
37
-
-
0034690311
-
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
-
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF & Davis RJ 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. New England Journal of Medicine 342 1171-1177.
-
(2000)
New England Journal of Medicine
, vol.342
, pp. 1171-1177
-
-
Trainer, P.J.1
Drake, W.M.2
Katznelson, L.3
Freda, P.U.4
Herman-Bonert, V.5
van der Lely, A.J.6
Dimaraki, E.V.7
Stewart, P.M.8
Friend, K.E.9
Vance, M.L.10
Besser, G.M.11
Scarlett, J.A.12
Thorner, M.O.13
Parkinson, C.14
Klibanski, A.15
Powell, J.S.16
Barkan, A.L.17
Sheppard, M.C.18
Malsonado, M.19
Rose, D.R.20
Clemmons, D.R.21
Johannsson, G.22
Bengtsson, B.A.23
Stavrou, S.24
Kleinberg, D.L.25
Cook, D.M.26
Phillips, L.S.27
Bidlingmaier, M.28
Strasburger, C.J.29
Hackett, S.30
Zib, K.31
Bennett, W.F.32
Davis, R.J.33
more..
-
38
-
-
0035944825
-
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
-
van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA & Thorner MO 2001 Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358 1754-1759.
-
(2001)
Lancet
, vol.358
, pp. 1754-1759
-
-
van der Lely, A.J.1
Hutson, R.K.2
Trainer, P.J.3
Besser, G.M.4
Barkan, A.L.5
Katznelson, L.6
Klibanski, A.7
Herman-Bonert, V.8
Melmed, S.9
Vance, M.L.10
Freda, P.U.11
Stewart, P.M.12
Friend, K.E.13
Clemmons, D.R.14
Johannsson, G.15
Stavrou, S.16
Cook, D.M.17
Phillips, L.S.18
Strasburger, C.J.19
Hackett, S.20
Zib, K.A.21
Davis, R.J.22
Scarlett, J.A.23
Thorner, M.O.24
more..
-
39
-
-
0031963796
-
Prognostic significance of serial changes in left ventricular mass in essential hypertension
-
Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G & Porcellati C 1998 Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97 48-54.
-
(1998)
Circulation
, vol.97
, pp. 48-54
-
-
Verdecchia, P.1
Schillaci, G.2
Borgioni, C.3
Ciucci, A.4
Gattobigio, R.5
Zampi, I.6
Reboldi, G.7
Porcellati, C.8
-
40
-
-
0025770664
-
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
-
Weber KT & Brilla CG 1991 Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83 1849-1865.
-
(1991)
Circulation
, vol.83
, pp. 1849-1865
-
-
Weber, K.T.1
Brilla, C.G.2
|